(Q48020790)

7 February 2018

review article

1 reference

title

Cardiac dysfunction in sepsis: new theories and clinical implications. (English)

1 reference

7 February 2018

1 reference

2

1 reference

7 February 2018

author name string

R M Grocott-Mason

series ordinal

1

1 reference

7 February 2018

publication date

1 April 1998

1 reference

7 February 2018

published in

Intensive Care Medicine

1 reference

7 February 2018

volume

24

1 reference

7 February 2018

issue

4

1 reference

7 February 2018

page(s)

286-295

1 reference

7 February 2018

https://scigraph.springernature.com/pub.10.1007/s001340050570

exact match

0 references

cites work

Toward a theory regarding the pathogenesis of the systemic inflammatory response syndrome: what we do and do not know about cytokine regulation

1 reference

https://api.crossref.org/works/10.1007%2FS001340050570

Profound but reversible myocardial depression in patients with septic shock

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS001340050570

Left ventricular performance in septic shock: reversible segmental and global abnormalities.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS001340050570

Depressed left ventricular performance. Response to volume infusion in patients with sepsis and septic shock

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS001340050570

Left ventricular systolic and diastolic function in septic shock.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS001340050570

Sepsis/septic shock: participation of the microcirculation: an abbreviated review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS001340050570

The cardiac endothelium: cardioactive mediators

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS001340050570

A circulating myocardial depressant substance in humans with septic shock. Septic shock patients with a reduced ejection fraction have a circulating factor that depresses in vitro myocardial cell performance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS001340050570

Tumor necrosis factor alpha and interleukin 1beta are responsible for in vitro myocardial cell depression induced by human septic shock serum

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS001340050570

The cardiovascular response of normal humans to the administration of endotoxin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS001340050570

Endotoxemia in human septic shock

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS001340050570

Cellular basis for the negative inotropic effects of tumor necrosis factor-alpha in the adult mammalian heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS001340050570

Shock and tissue injury induced by recombinant human cachectin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS001340050570

Endotoxin and tumor necrosis factor challenges in dogs simulate the cardiovascular profile of human septic shock

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS001340050570

Anti-cachectin/TNF monoclonal antibodies prevent septic shock during lethal bacteraemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS001340050570

Tumor necrosis factor-alpha gene and protein expression in adult feline myocardium after endotoxin administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS001340050570

Occupancy of platelet receptors for platelet-activating factor in patients with septicemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS001340050570

Effects of acetyl glyceryl ether of phosphorylcholine (platelet activating factor) on ventricular preload, afterload, and contractility in dogs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS001340050570

Effect of the platelet-activating factor antagonist, TCV-309, and the cyclo-oxygenase inhibitor, ibuprofen, on the haemodynamic changes in canine experimental endotoxic shock

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS001340050570

The effects of ibuprofen on the physiology and survival of patients with sepsis. The Ibuprofen in Sepsis Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS001340050570

Nitric oxide and cardiac function.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS001340050570

Induction and potential biological relevance of a Ca(2+)-independent nitric oxide synthase in the myocardium

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS001340050570

Paracrine coronary endothelial control of left ventricular function in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS001340050570

Dobutamine enhances cardiodepressant effects of receptor-mediated coronary endothelial stimulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS001340050570

Nitric oxide can increase heart rate by stimulating the hyperpolarization-activated inward current, I(f).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS001340050570

Biochemistry of Nitric Oxide and Its Redox-Activated Forms

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS001340050570

Abnormal contractile function due to induction of nitric oxide synthesis in rat cardiac myocytes follows exposure to activated macrophage-conditioned medium

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS001340050570

L-canavanine, an inhibitor of inducible nitric oxide synthase, improves venous return in endotoxemic rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS001340050570

Natural resistance and nitric oxide

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS001340050570

Role of endothelium-derived nitric oxide in the modulation of canine myocardial mitochondrial respiration in vitro. Implications for the development of heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS001340050570

Apparent hydroxyl radical production by peroxynitrite: implications for endothelial injury from nitric oxide and superoxide

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS001340050570

The lethal effects of cytokine-induced nitric oxide on cardiac myocytes are blocked by nitric oxide synthase antagonism or transforming growth factor beta

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS001340050570

Treatment of gram-negative bacteremia and septic shock with HA-1A human monoclonal antibody against endotoxin. A randomized, double-blind, placebo-controlled trial. The HA-1A Sepsis Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS001340050570

Administration of anti-TNF antibody improves left ventricular function in septic shock patients. Results of a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS001340050570

Assessment of the safety and efficacy of the monoclonal anti-tumor necrosis factor antibody-fragment, MAK 195F, in patients with sepsis and septic shock: a multicenter, randomized, placebo-controlled, dose-ranging study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS001340050570

INTERSEPT: an international, multicenter, placebo-controlled trial of monoclonal antibody to human tumor necrosis factor-alpha in patients with sepsis. International Sepsis Trial Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS001340050570

A controlled clinical trial of high-dose methylprednisolone in the treatment of severe sepsis and septic shock

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS001340050570

Methylene blue administration in septic shock: a clinical trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS001340050570

Tumor Necrosis Factor Soluble Receptors in Patients With Various Degrees of Congestive Heart Failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS001340050570

Differential Regulation of Cyclo-Oxygenase-1 and Cyclo-Oxygenase-2 Gene Expression by Lipopolysaccharide Treatmentin vivoin the Rat

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS001340050570

High-energy phosphates in heart, liver, kidney, and skeletal muscle of endotoxemic rats.

21 January 2018

1 reference

12 December 2020

Interleukin-1 beta modulates myocardial contraction via dexamethasone sensitive production of nitric oxide

1 reference

12 December 2020

Pathogenetic mechanisms of septic shock

1 reference

12 December 2020

Intracellular cyclic GMP receptor proteins.

1 reference

12 December 2020

An obligatory role for nitric oxide in autonomic control of mammalian heart rate

1 reference

12 December 2020

Negative inotropic effects of cytokines on the heart mediated by nitric oxide

1 reference

12 December 2020

Altered responses to bacterial infection and endotoxic shock in mice lacking inducible nitric oxide synthase

1 reference

12 December 2020

Coronary hemodynamics and myocardial metabolism of lactate, free fatty acids, glucose, and ketones in patients with septic shock

1 reference

12 December 2020

Nitric oxide synthase inhibition by L-NAME in leukocytopenic patients with severe septic shock

1 reference

12 December 2020

Endothelial inhibition of myofilament calcium response in intact cardiac myocytes

1 reference

12 December 2020

Influence of a Myocardial Depressant Factor on Physiologic Properties of Cardiac Muscle

1 reference

12 December 2020

Effects of TNF-alpha on [Ca2+]i and contractility in isolated adult rabbit ventricular myocytes

1 reference

12 December 2020

Inhibition of myocardial crossbridge cycling by hypoxic endothelial cells: a potential mechanism for matching oxygen supply and demand?

1 reference

12 December 2020

8-bromo-cGMP reduces the myofilament response to Ca2+ in intact cardiac myocytes

1 reference

12 December 2020

Cytokine-stimulated nitric oxide production inhibits mitochondrial activity in cardiac myocytes

1 reference

12 December 2020

G protein-mediated suppression of L-type Ca2+ current by interleukin-1 beta in cultured rat ventricular myocytes

1 reference

12 December 2020

Basal release of nitric oxide augments the Frank-Starling response in the isolated heart

1 reference

12 December 2020

Leukocytes and decreased left-ventricular contractility during endotoxemia in rabbits

1 reference

12 December 2020

Modulation of left ventricular relaxation in isolated ejecting heart by endogenous nitric oxide

1 reference

12 December 2020

Decreased left ventricular contractility during porcine endotoxemia is not prevented by ibuprofen

1 reference

12 December 2020

Effects of a nitric oxide synthase inhibitor in humans with septic shock

1 reference

12 December 2020

Inducible nitric oxide synthase and tumor necrosis factor-alpha in myocardium in human dilated cardiomyopathy

1 reference

12 December 2020

Induction of NO synthase in rat cardiac microvascular endothelial cells by IL-1 beta and IFN-gamma

1 reference

12 December 2020

Nitric oxide synthase inhibition does not prevent cardiac depression in endotoxic shock

1 reference

12 December 2020

Nitric oxide-dependent parasympathetic signaling is due to activation of constitutive endothelial (type III) nitric oxide synthase in cardiac myocytes

1 reference

12 December 2020

Treatment of septic shock with the tumor necrosis factor receptor:Fc fusion protein. The Soluble TNF Receptor Sepsis Study Group

1 reference

12 December 2020

Pseudomonas aeruginosa exotoxin A enhances automaticity and potentiates hypoxic depression of isolated rat hearts

1 reference

12 December 2020

The coronary circulation in human septic shock

1 reference

12 December 2020

Partial inhibition of protein synthesis by Pseudomonas exotoxin A deranges catecholamine sensitivity of cultured rat heart myocytes

1 reference

12 December 2020

Platelet-activating factor receptor antagonist BN 52021 in the treatment of severe sepsis: a randomized, double-blind, placebo-controlled, multicenter clinical trial. BN 52021 Sepsis Study Group.

1 reference

12 December 2020

Myocardial morphometric changes related to decreased contractility after endotoxin

1 reference

12 December 2020

Right ventricular dysfunction and dilatation, similar to left ventricular changes, characterize the cardiac depression of septic shock in humans

1 reference

12 December 2020

Tumour necrosis factor and inducible nitric oxide synthase in dilated cardiomyopathy

1 reference

12 December 2020

Nitric oxide synthase inhibitor alters papillary muscle force-frequency relationship.

1 reference

12 December 2020

A controlled clinical trial of E5 murine monoclonal IgM antibody to endotoxin in the treatment of gram-negative sepsis. The XOMA Sepsis Study Group

1 reference

12 December 2020

Acute effects of nitric oxide on left ventricular relaxation and diastolic distensibility in humans. Assessment by bicoronary sodium nitroprusside infusion

1 reference

12 December 2020

Novel cardiac myofilament desensitizing factor released by endocardial and vascular endothelial cells

1 reference

12 December 2020

Nitric oxide production within cardiac myocytes reduces their contractility in endotoxemia

1 reference

12 December 2020

Glucocorticoids regulate inducible nitric oxide synthase by inhibiting tetrahydrobiopterin synthesis and L-arginine transport

1 reference

12 December 2020

Cardiovascular performance with E. coli challenges in a canine model of human sepsis

1 reference

12 December 2020

Monoclonal antibody to TNF in severe septic shock

1 reference

12 December 2020

Endotoxin-induced myocardial dysfunction: is there a role for nitric oxide?

1 reference

12 December 2020

L-arginine pathway in the sepsis syndrome.

1 reference

12 December 2020

Evidence for an early lipid soluble cardiodepressant factor in rat serum after a sublethal dose of endotoxin

1 reference

12 December 2020

Platelet-activating factor antagonism improves ventricular contractility in endotoxemia

1 reference

12 December 2020

Characterization of inducible nitric oxide synthase expression in endotoxemic rat cardiac myocytes in vivo and following cytokine exposure in vitro

1 reference

12 December 2020

Cytokines, nitrite/nitrate, soluble tumor necrosis factor receptors, and procalcitonin concentrations: comparisons in patients with septic shock, cardiogenic shock, and bacterial pneumonia

1 reference

12 December 2020

Identifiers

DOI

10.1007/S001340050570

1 reference

7 February 2018

PubMed ID

9609405

1 reference

7 February 2018